Cotinine Screening Devices Market by Device Type, Sample & Region | Forecast 2022 to 2032

Name: Cotinine Screening Devices Market by Device Type, Sample & Region | Forecast 2022 to 2032
Creator: Future Market Insights
Published: 2022-10-10 00:00:00
License: 暂无描述

www.futuremarketinsights.com2022-10-10 更新2025-01-15 收录

下载链接：

https://www.futuremarketinsights.com/reports/cotinine-screening-devices-market

下载链接

链接失效反馈

官方服务：

资源简介：

<p>The global <strong>cotinine screening devices market</strong> recorded sales worth US$ 429.9 Million in the year 2021. The market is expected to expand at a cumulative CAGR of 4.7% and will grow 1.4X by the end of 2032, in which the sales are anticipated to be worth US$ 645 Million</p><table><tbody><tr><th scope='row'>Data Points</th><td>Market Insights</td></tr><tr><th scope='row'>Market Value 2022</th><td>US$ 450.3 Million</td></tr><tr><th scope='row'>Market Value 2029</th><td>US$ 621.4 Million</td></tr><tr><th scope='row'>CAGR 2022 to 2029</th><td>4.7%</td></tr><tr><th scope='row'>Share of top 5 countries</th><td>71.9%</td></tr><tr><th scope='row'>Key Players</th><td>The Key players in the Cotinine Screening Devices market are Abbott Laboratories, AlcoPro, Jant Pharmacal Corporation, Sinocare Inc., Mossman Associates, Nano-Ditech Corp, LifeSign LLC, ALFA Scientific, Ameritek USA., Hangzhou Clongene Biotech Co., and Germaine Laboratories, Inc.</td></tr></tbody></table><p>How The Market Progressed Till June 2022?</p><table><tbody><tr><th scope='row'>Particulars</th><td>Details</td></tr><tr><th scope='row'>H1, 2021</th><td>4.69%</td></tr><tr><th scope='row'>H1, 2022 Projected</th><td>4.71%</td></tr><tr><th scope='row'>H1, 2022 Outlook</th><td>4.61%</td></tr><tr><th scope='row'>BPS Change - H1, 2022 (O) - H1, 2022 (P)</th><td>(-) 10 ↓</td></tr><tr><th scope='row'>BPS Change - H1, 2022 (O) - H1, 2021</th><td>(-) 9</td></tr></tbody></table><p>Scope of the report</p><table><tbody><tr><th scope='row'>Attributes</th><td>Details</td></tr><tr><th scope='row'>Forecast Period</th><td>2022 to 2029</td></tr><tr><th scope='row'>Historic Data available for</th><td>2014 to 2021</td></tr><tr><th scope='row'>Market Analysis</th><td>USD Million for value</td></tr><tr><th scope='row'>Key Countries covered</th><td>USA, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, and South Africa.</td></tr><tr><th scope='row'>Key Segments Covered</th><td>Device Type, Sample Type, End-User & Region</td></tr><tr><th scope='row'>Key Companies Profiled</th><td><ul><li>Abbott Laboratories</li><li>AlcoPro Inc.</li><li>Jant Pharmacal Corporation</li><li>Sinocare Inc.,(PTS Diagnostics)</li><li>Mossman Associates</li><li>Nano-Ditech Corp</li><li>LifeSign LLC</li><li>ALFA Scientific</li><li>Ameritek USA.</li><li>Hangzhou Clongene Biotech Co.</li><li>Germaine Laboratories, Inc.</li></ul></td></tr><tr><th scope='row'>Report Coverage</th><td>Market Forecast, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives</td></tr><tr><th scope='row'>Customization and Pricing</th><td>Available upon request</td></tr></tbody></table>

<p>全球尼古丁筛查设备市场在2021年实现了4.299亿美元的销售业绩。预计该市场将以4.7%的复合年增长率持续扩张，至2032年将增长1.4倍，届时销售额预计将达到6.45亿美元。</p><table><tbody><tr><th scope='row'>数据点</th><td>市场洞察</td></tr><tr><th scope='row'>2022年市场价值</th><td>4.503亿美元</td></tr><tr><th scope='row'>2029年市场价值</th><td>6.214亿美元</td></tr><tr><th scope='row'>2022年至2029年复合年增长率</th><td>4.7%</td></tr><tr><th scope='row'>前五国的市场份额</th><td>71.9%</td></tr><tr><th scope='row'>主要参与者</th><td>尼古丁筛查设备市场的主要参与者包括阿伯特实验室（Abbott Laboratories）、AlcoPro、Jant Pharmacal Corporation、Sinocare Inc.、Mossman Associates、Nano-Ditech Corp、LifeSign LLC、ALFA Scientific、Ameritek USA、杭州康龙生物科技有限公司（Hangzhou Clongene Biotech Co.）和Germaine Laboratories, Inc.</td></tr></tbody></table><p>市场至2022年6月的发展情况如何？</p><table><tbody><tr><th scope='row'>特定事项</th><td>详细情况</td></tr><tr><th scope='row'>2021年上半年度</th><td>4.69%</td></tr><tr><th scope='row'>2022年上半年度预测</th><td>4.71%</td></tr><tr><th scope='row'>2022年上半年度展望</th><td>4.61%</td></tr><tr><th scope='row'>2022年上半年度（预期）- 2022年上半年度（预测）BPS变动</th><td>(-) 10 ↓</td></tr><tr><th scope='row'>2022年上半年度（预期）- 2021年上半年度BPS变动</th><td>(-) 9</td></tr></tbody></table><p>报告范围</p><table><tbody><tr><th scope='row'>属性</th><td>详细情况</td></tr><tr><th scope='row'>预测期</th><td>2022年至2029年</td></tr><tr><th scope='row'>可提供的历史数据</th><td>2014年至2021年</td></tr><tr><th scope='row'>市场分析</th><td>以亿美元计的市值</td></tr><tr><th scope='row'>涵盖的关键国家</th><td>美国、加拿大、德国、英国、法国、意大利、西班牙、俄罗斯、中国、日本、韩国、印度、泰国、马来西亚、印度尼西亚、澳大利亚、新西兰、海湾合作委员会国家、土耳其和南非。</td></tr><tr><th scope='row'>涵盖的关键细分市场</th><td>设备类型、样本类型、终端用户及地区</td></tr><tr><th scope='row'>概述的关键公司</th><td><ul><li>阿伯特实验室</li><li>AlcoPro Inc.</li><li>Jant Pharmacal Corporation</li><li>Sinocare Inc.，（PTS Diagnostics）</li><li>Mossman Associates</li><li>Nano-Ditech Corp</li><li>LifeSign LLC</li><li>ALFA Scientific</li><li>Ameritek USA.</li><li>杭州康龙生物科技有限公司</li><li>Germaine Laboratories, Inc.</li></ul></td></tr><tr><th scope='row'>报告覆盖范围</th><td>市场预测、竞争情报、驱动力、限制因素、机遇与威胁分析、市场动态与挑战、战略增长举措</td></tr><tr><th scope='row'>定制与定价</th><td>根据要求提供</td></tr></tbody></table>

提供机构：

Future Market Insights